Cedars-Sinai Technology Ventures-led startup Gravidas Diagnostics Inc. has been awarded a $3 million federal grant from the Advanced Research Projects Agency for Health (ARPA-H) to develop a first-of-its-kind, affordable, home-based fingerstick test for early detection of preeclampsia, a serious pregnancy complication.
